Metabolomic Biomarkers to Predict and Diagnose Cystic Fibrosis Pulmonary Exacerbations: A Systematic Review

INTRODUCTION: Metabolomics is an emerging area of research and has the potential to identify clinical biomarkers for predicting or diagnosing cystic fibrosis (CF) pulmonary exacerbations (PEx). OBJECTIVE: To identify clinically promising metabolites across different sample sources that can be used t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Anna-Lisa V., Haas, Dominic, Bouchard, Mégane, Quon, Bradley S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192952/
https://www.ncbi.nlm.nih.gov/pubmed/35712620
http://dx.doi.org/10.3389/fped.2022.896439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192952/
https://www.ncbi.nlm.nih.gov/pubmed/35712620
http://dx.doi.org/10.3389/fped.2022.896439

Ejemplares similares